This requirement is supported by the demonstration that MT1-MMP is capable of cleaving MMP-2 to form a pro-MMP-2/MT1-MMP/TIMP-2 complex, which enhances the concentration of active MMP-2 at the leading edge of invading cancer cells [21]. This evidence concerns the gene MMP14 and cancer.